DeutschNewstral
Article
bizjournals.com on 2019-01-15 12:07
FDA pilot program could help Wave avoid orphan-drug pitfalls
Related news
Lundbeck's Carnexiv gets FDA orphan drug statusdailyherald.com- SA biotech gets FDA orphan drug designationbizjournals.com
FDA Approving Orphan Drugs At A Record Pacejdsupra.com- FDA finalizes guidance on Orphan Drug “sameness” of gene therapiesjdsupra.com
Sapience Therapeutics ST-36 receives orphan drug designation from FDAwestfaironline.com- MProQR shares rises on FDA orphan drug designationmarketwatch.com
Avoid pitfallsArkansas Online
FDA warns peanut allergic to avoid cuminThe Salt Lake Tribune
SFUSD suspends testing pilot after FDA warningSF Examiner- FDA Rejects Otsuka’s Assertions of Orphan Drug Exclusivity for Abilify®, Allowing Generics to Proceedjdsupra.com
- Otsuka’s Orphan Drug Exclusivity Claims: FDA Rips Off the Band-Aid Earlyjdsupra.com
- MSeres shares drop 7% after news of FDA orphan drug designation for ulcerative colitis therapymarketwatch.com
- Imbrium Therapeutics receives FDA orphan drug designation for biliary tract cancer drugwestfaironline.com
- MAkari Therapeutics shares soar 13% premarket after FDA grants Orphan Drug designation to nomacopanmarketwatch.com
- Annovis Bio seeks orphan drug status from FDA for its lead new drug candidatebizjournals.com
- Durham drug developer gets FDA cash to work on orphan disease drugbizjournals.com
- FDA Finalizes Guidance On Interpretation Of Orphan Drug “Sameness” For Gene Therapy Productsjdsupra.com
- FDA Issues Orphan Drug Exclusivity Policy That Could be a Catalyst for Future Litigationjdsupra.com
- FDA Adjustment to Orphan Drug Review May Indicate Increased Scrutiny of Designationsjdsupra.com